FREE Membership Sign in

JavaScript is disabled in your browser.

In order visualise this page, please follow these steps.

Association raises concerns about proposed patented medicine guidelines

Visibility360, PDF version to share

By Kate McCaffery | Oct. 21, 2022, 10:42 a.m.

Photo: Freepik | aleksandarlittlewolf

Pharmaceutical association says draft guidelines will exacerbate an already unpredictable regulatory environment.

This article is reserved to PRO Level subscribers

Discover the PRO Level

The most popular in Health

Drug plan sponsors encouraged to set up usage guardrails for new therapies

Women over 65 less likely than men to visit medical specialists for non-emergencies

Employee health and wellness metrics decline

Make your business shine with Visibility360!

Get a PDF version to share in your networks.

I'm interested

Headlines

Quebec flood zone map raises concerns even before its release

Tips for increasing your firm’s value

Agent who defrauded retired couple banned from securities registration

Related topics …

Flash

Quebec flood zone map raises concerns even before its release

Tips for increasing your firm’s value

Ontario regulator publishes guidance for comment

Insurers pushing their limits in accelerated underwriting

PATENTED MEDICINE PRICES REVIEW BOARD (PMPRB)

Canadian list prices for patented medicines remain among the highest in the world

Public drug plans not immune to the rising cost of medications

Industry advises Patented Medicines Pricing Review Board on new guidelines

Government forms Canadian Drug Agency

Regulation

National Flood Insurance Program promised again in budget

Mutual fund rep fined close to $1.7-million

Insurers likely to benefit from adding obesity drugs to benefits coverage

Sanctions for pre-signed forms levied against former Fredericton rep

Compliance

Regulator revokes healthcare service providers’ licenses

Regulator comes down on the whole industry for Take-All-Comers non-compliance

Regulator imposes $600,000 in administrative penalties

Serving clients without regulatory approval or adequate controls costs firm $100,000

Analytic

Embracing artificial intelligence is crucial for industry

New tool available to help municipalities mitigate flood risk

Pension funding rises in March

Six out of ten workers not performing to their full potential

Medication

Drug plan sponsors encouraged to set up usage guardrails for new therapies

Employee health and wellness metrics decline

Women over 65 less likely than men to visit medical specialists for non-emergencies

One-third of younger adults report using cannabis in the past year